m
Recent Posts
Connect with:
Sunday / November 22.
Homeminews (Page 1236)

Ozurdex (dexamethasone 700μg) sustained release intravitreal implant is listed on the Pharmaceutical Benefits Scheme (PBS) for patients with non-infectious posterior

Marking the launch of the inaugural Macula Month (May), study results released today by Macular Disease Foundation Australia highlight the need for Australians, particularly

Industry representatives have welcomed the new Academy of Advanced Ophthalmic Optics.  Launched in Sydney by optometry/dispenser duo Thao and Grant Hannaford, the

UNSW scientists have bridged a key knowledge gap in the diagnosis of glaucoma, allowing observable damage to the optic nerve caused by the condition

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.